How effective is nicotine replacement therapy in helping people to stop smoking?
- PMID: 8179658
- PMCID: PMC2539178
- DOI: 10.1136/bmj.308.6920.21
How effective is nicotine replacement therapy in helping people to stop smoking?
Erratum in
- BMJ 1994 Mar 5;308(6929):626
Abstract
Objective: To assess the efficacy of nicotine replacement therapy in helping people to stop smoking.
Design: Analysis of the results of 28 randomised trials of nicotine 2 mg chewing gum, six trials of nicotine 4 mg chewing gum, and six trials of nicotine transdermal patch.
Subjects and setting: Subjects were self referred (responding to advertisements or attending anti-smoking clinics) in 20 trials and invited (general practice or hospital patients) in 20. Therapists in self referred trials were generally experienced in helping people stop smoking but not in invited trials.
Main outcome measure: Efficacy was defined as difference in percentages of treated and control subjects who had stopped smoking at one year.
Results: Efficacy was highly significant (P < 0.001) for both gum and patch. Nicotine 2 mg chewing gum had an overall efficacy of 6% (95% confidence interval 4% to 8%), greater in self referred subjects than in invited subjects (11% v 3%). Efficacy depended on the extent of dependence on nicotine as assessed by a simple questionnaire; it was 16% (7% to 25%) in "high dependence" smokers, but in "low dependence" smokers there was no significant effect. The 4 mg gum was effective in about one third of "high dependence" smokers. The efficacy of the nicotine patch (9% (6% to 13%) overall) was less strongly related to nicotine dependence, perhaps because the patch cannot deliver a bolus of nicotine to satisfy craving.
Conclusions: Both gum and patch are effective aids to help nicotine dependent smokers who seek help in stopping. Among the most highly nicotine dependent smokers (those craving a cigarette on waking) the 4 mg gum is the most effective form of replacement therapy; it could enable one third to stop. In less highly dependent smokers the different preparations are comparable in their efficacy but the patch offers greater convenience and minimal need for instruction in its use. Overall, nicotine replacement therapy could enable about 15% of smokers who seek help in stopping smoking to give up the habit.
Comment in
- ACP J Club. 1994 Jul-Aug;121 Suppl 1:18-9
-
Nicotine replacement therapy.BMJ. 1994 Feb 12;308(6926):475. doi: 10.1136/bmj.308.6926.475a. BMJ. 1994. PMID: 8124198 Free PMC article. No abstract available.
Similar articles
-
Nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146. doi: 10.1002/14651858.CD000146.pub3. Cochrane Database Syst Rev. 2008. PMID: 18253970 Updated. Review.
-
Nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2000;(2):CD000146. doi: 10.1002/14651858.CD000146. Cochrane Database Syst Rev. 2000. PMID: 10796494 Updated. Review.
-
Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.Br J Gen Pract. 1996 Mar;46(404):145-8. Br J Gen Pract. 1996. PMID: 8731618 Free PMC article. Clinical Trial.
-
Electronic cigarettes for smoking cessation and reduction.Cochrane Database Syst Rev. 2014;(12):CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. Cochrane Database Syst Rev. 2014. PMID: 25515689 Review.
-
Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.Pediatrics. 2005 Apr;115(4):e407-14. doi: 10.1542/peds.2004-1894. Pediatrics. 2005. PMID: 15805342 Clinical Trial.
Cited by
-
Interventions for Alcoholics Who Smoke.Alcohol Health Res World. 1996;20(2):111-117. Alcohol Health Res World. 1996. PMID: 31798159 Free PMC article.
-
Acute and chronic interactive treatments of serotonin 5HT2C and dopamine D1 receptor systems for decreasing nicotine self-administration in female rats.Pharmacol Biochem Behav. 2019 Nov;186:172766. doi: 10.1016/j.pbb.2019.172766. Epub 2019 Aug 27. Pharmacol Biochem Behav. 2019. PMID: 31470021 Free PMC article.
-
Motivations and Limitations Associated with Vaping among People with Mental Illness: A Qualitative Analysis of Reddit Discussions.Int J Environ Res Public Health. 2016 Dec 22;14(1):7. doi: 10.3390/ijerph14010007. Int J Environ Res Public Health. 2016. PMID: 28025516 Free PMC article.
-
Nicotine dependence and biochemical exposure measures in the second trimester of pregnancy.Nicotine Tob Res. 2014 Feb;16(2):145-54. doi: 10.1093/ntr/ntt127. Epub 2013 Aug 13. Nicotine Tob Res. 2014. PMID: 23943839 Free PMC article. Clinical Trial.
-
Smoking characteristics and comorbidities in the power to quit randomized clinical trial for homeless smokers.Nicotine Tob Res. 2013 Jan;15(1):22-8. doi: 10.1093/ntr/nts030. Epub 2012 May 15. Nicotine Tob Res. 2013. PMID: 22589422 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical